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ABSTRACT
Introduction: Mast cells (MC) are multifunctional secretory 
cells characterized by numerous large metachromatic stain-
ing protease-rich intracellular granules. They are derived from 
hematopoietic progenitor cells in bone marrow and do not 
mature into terminally differentiated cells until they reach the 
tissue or organ in which they become resident. They play a 
vital role in a number of defense and repair mechanisms due to 
their strategic location in the connective tissue at the interface 
with the microvasculature. 
Objectives: This review attempts to help improve our under-
standing on the types of MC, their morphology, staining charac-
teristics, distribution, biological function, and their pathogenesis 
in inflammation, oral potentially malignant disorders, and oral 
squamous cell carcinoma. We hope this review recognizes the 
integral role of MC in oral pathological disorders and facilitates 
the opening of novel approaches to better therapies for improv-
ing the quality of life.
Conclusion: Mast cells has shown to remodel extracellular 
matrix during wound healing. The entire ambit of allergic and 
hypersensitivity reactions are the adverse effects produced by 
the degranulation of MC. They participate in many inflammatory 
oral diseases as they possess diverse roles ranging from pro-
inflammatory to immuno-modulatory. They accumulate at the 
boundary between healthy tissues and malignancies and are 
found in close association with blood vessels within the tumor 
microenvironment as they play an early role in angiogenesis. 
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INTRODUCTION
Mast cells (MC) have fascinated the medical community 
over decades because of their metachromatic staining 
protease-rich large cytoplasmic granules and due to the 
general lack of true understanding of their biological 
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function.1 von Recklinghausen (1863), Kuhne (1864), 
Friedlander (1867), and Flemming (1867) among others 
together may be considered as the earliest researchers 
who first identified and described MC.2 Many later 
researchers noted their perivascular habitat, but it was 
the German biologist Paul Ehrlich (1877) who coined 
the term “mastzellen,” which meant “sleek, fat, and well 
fed.”2 He was of the opinion that they had a role in nutri-
tion as the MC were found in tissues where nutrition was 
enhanced and he believed that the intracellular granules 
were phagocytosed nutrients.2 Some experts refer to MC 
as “unicellular endocrine glands,” because of their ability 
to release a wide variety of chemical mediators that have 
potent biological actions, such as recruitment of inflam-
matory cells, phagocytosis, stimulation of fibroblasts, neo-
angiogenesis, and release of few vasoactive substances.3 
They exhibit an array of surface molecules and immune 
response receptors, which give them the capacity to react 
against specific and nonspecific stimuli, hence playing 
an important role in host defense mechanism, innate 
immunity, homeostasis, remodeling, and fibrosis.4,5 Many 
theories have been proposed toward the origin of these 
cells, including from the pericytes located along the capil-
laries.5 They are now considered to be of hematopoietic 
origin and are derived from the bone marrow cells.5 They 
circulate as committed progenitors and on an inflamma-
tory stimuli traverse from the vascular space and mature 
in the peripheral tissues.2
In this review we provide an overview of the types 
of MC, their morphology, staining characteristics, dis-
tribution, biological function, and their potential role 
in pathological conditions of the oral cavity. Through 
the understanding of MC, we hope to help researchers 
in the development of novel interventions to alter MC 
response in the pathological environment to help inhibit 
the developing pathology.
CLASSIFICATION
•	 Based	on	age	of	MC
– Young MC (type I): Stains metachromatically blue 
and	 homogeneously	with	 toluidine	 blue	 (TB)	
and stains negative for periodic acid Schiff (PAS) 
reaction6
– Mature MC (type II): Stains metachromatically 
violet	and	with	granularity	on	TB	and	stains	posi-
tive for PAS6
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•	 Based	on	differences	in	neutral	protease	composition,	
ultrastructure, and dependency on T-lymphocyte 
function
– MCT cell: Containing tryptase
7
– MCTC cell: Containing tryptase and chymase
7
– Immature forms have been described which have 
indistinct ultrastructural features but have the 
same protease compositions as of their mature 
counterparts.7
•	 Based	on	tissue	distribution,	staining	characteristics,	
and presence of proteases
– Mucosal MC: Positive for chymase8,9
– Connective tissue MC: Positive for both tryptase 
and chymase8,9
•	 MC	in	human	gingiva
– Typical MC (TMC): Having distinct metachromatic 
cytoplasmic granules with definite cytoplasmic 
boundaries.8
– Atypical MC (AMC): Having indistinct or faint 
metachromatic material of granular, linear, vacu-
olated, or homogeneous appearance partially or 
totally surrounding the nucleus, and with indefi-
nite cytoplasmic boundaries.8
Morphology
Light microscopic study of MC revealed four basic cell 
morphologies: round, ovoid, spindle or elongated, and 
pseudopodia.10 Tissue MC have small nucleus with a mean 
diameter of 4 µ and have a round-oval shape, which may 
sometimes be longitudinally stretched, indented, kidney, 
or fusiform shaped.2 The cells have polymorphous cyto-
plasmic contour and appear as oval, pyriform, spindle, or 
star shaped due to the aggregation of the intracytoplasmic 
granules.2 The granules are often so numerous that they 
may obliterate the view of the cell nucleus. Oval and 
oblong MC vary in diameter from 3.5 to 14 µ and in some 
instances may attain 28 µ.8 The intracytoplasmic granules 
are spherical-oval membrane-bounded organelles with 
a mean diameter of 0.2 to 0.4 µ.8 Often empty vacuoles 
representing discharged granules are present.8 Changes 
in the morphology may occur due to the intrinsic (genetic 
origin, ameboid movement, physiological conditions) 
and/or extrinsic factors (environmental factors, such as 
the medium of fixation, embedding, staining).2 Under the 
electron microscope, the nucleus appeared to lie more or 
less centrally with clumped chromatin.10 The cells had an 
irregular outline with numerous characteristic cytoplasmic 
processes in the form of pseudopodia and microvilli.10 
The cytoplasm contained numerous mitochondria, fibril-
lar structures, sparse smooth endoplasmic reticulum, 
diffusely distributed ribosomes, well-developed golgi 
complex, and scattered secretory granules.10
Staining Characteristics
Under hematoxylin and eosin (H&E), MC are not 
prominent and can be easily overlooked.4	Basic	aniline	
dyes, such as ethylene blue or crystal violet are classi-
cally used to demonstrate their presence.4 MC granules 
have a strong affinity for basic dyes and they stain the 
granules metachromatically, with the blue dyes giving 
a red stain and the red dyes giving a yellow stain.2 The 
metachromasia is due to the presence of large amount 
of sulfated glycosaminoglycan heparin in the granules.4 
The	other	 basic	dyes	 that	 stain	MC	are	 thionine,	 TB,	
methylene blue, methylene violet, cresyl violet, brilliant 
cresyl blue, amethyst, acridine red, neutral red, pyronine, 
safranine, azure, and acridine orange.2,11 Positivity for 
PAS, alcian blue, astral blue, and colloidal iron suggests 
the presence of acid mucopolysaccharides.4 The different 
staining characteristics of MC within the same tissue and 
between tissues suggests the heterogeneity of their chemi-
cal constituents or the difference in cell maturation.2 MC 
have shown immunopositivity toward bcl-x(L), CD68R, 
CD45, CD117 (c-kit), and HLA-DR.29 CD2 may be a novel 
useful marker in mastocytosis, since in other pathologic 
conditions MC are CD2 negative.12
Distribution
MC are granular secretory cells seen in the underlying 
connective tissue of the oral mucosa.13 MC are abun-
dant in the bone marrow, serous membranes, around 
superficial small vessels or capillaries of all organs, 
microvascular endothelium of the oral mucosa, and in 
the extremities including face, hands, and feet.2,5 They 
are seen in close proximity to the basement membranes 
of blood vascular channels and nerves as a result of their 
interaction with the laminin-specific receptor CD49f 
(a6/pi) integrin.14 Large numbers of MC are found around 
the blood vessels in the gingiva and in the middle layers 
of lamina propria of the buccal mucosa.15 MC have been 
identified within the bilaminar tissues and vasculature of 
temperomandibular joints.16 MCT are almost exclusively 
found in the alveolar walls of the lungs and intestinal 
mucosa, while MCTC were seen more predominant 
around the blood vessels and the skin appendagial 
structures in the superficial dermis.7 MCT and MCTC 
demonstrated almost equal distribution in the connec-
tive tissue.7 Scars, cartilage, and bone are devoid of MC.2
Biological Function
MC arise from multipotent CD34+ precursors in the 
bone marrow and circulate in the peripheral blood as a 
granular monocytes.3 The progenitors differentiate from 
primitive cells under the influence of interleukin (IL)-3 
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and migrate to other parts of the body.12 On migrating 
into the connective tissues, these immature cells assume 
their typical granular morphology.5 MC has surface 
adhesion molecules integrins and c-kit that mediate 
binding to other cells and extracellular matrix (ECM) 
glycoproteins.17 MC activation results in the expression 
of adhesion molecules and their ligands, which help in 
their localization and migration. Extracellular matrix 
proteins, such as laminin of vascular and neural basement 
membrane, are important in the localization of MC.17 
Two principal cytokines IL-3 and stem cell factor (SCF) 
promotes MC proliferation and differentiation.1 IL-3 is 
important for its early proliferation, whereas SCF acts to 
maintain cell viability by suppressing apoptosis and by 
promoting maturation.1 MC along with the neutrophils, 
macrophages, and platelets play an important role in 
immunity. It contains chemical mediators, such as hista-
mine, tryptase, tumor necrosis factor (TNF), and IL that 
can increase fibroblast proliferation and act as chemotactic 
factor for neutrophils.1 Heparin, fibroblast growth factor 
(FGF), and vascular endothelial growth factor (VEGF) 
induce endothelial cell migration and angiogenesis.1  
MC induce and enhance angiogenesis via multiple 
interacting pathways including: (i) Release of potent 
proangiogenic factors, such as VEGF, bFGF, TGF-α, -β, 
and IL-8; (ii) proteinases and heparin that release heparin-
binding proangiogenic factors; (iii) histamine, VEGF, and 
certain lipid-derived mediators that induce microvascu-
lar hyperpermeability; (iv) chemotactic recruitment of 
monocytes/macrophages and lymphocytes; (v) activa-
tion of platelets; (vi) activation of neighboring non-MC, 
which release ECM degrading proteinases and SCF; (vii) 
auto- and paracrine stimulation of MC by SCF.17 As a 
result of ECM degradation and changes in the microen-
vironment, the MC populations may change in number, 
phenotype, and function. Chemical mediators in MC can 
be grouped into: (1) Preformed secretory granule media-
tors: Histamine, proteoglycans, serine proteases, carboxy-
peptidases; (2) lipid-derived mediators: Leukotriene – C4, 
D4, E4 (SRS-A), prostaglandin, platelet activating factor; 
(3) MC-derived cytokines: (a) Proinflammatory cytokines 
– TNFα, IL-1α, -1β, (b) mitogenic cytokines/growth 
factors: IL-3, -4, -5, -10, GM-csf, (c) immunomodulator 
cytokines: IL-1α, -1β, IL-4, -10, IFNγ.18
Mast Cells in Disease
Adverse effects of anaphylaxis and drug allergy are 
produced by the activation of MC and basophils.5 MC 
are activated to release inflammatory mediators during 
expressions of cell-mediated delayed hypersensitiv-
ity.5 Their proliferation in cellular immune response 
is regulated by the products of T lymphocytes.5 When 
immunoglobulin (Ig)-E antibodies are raised against a 
certain allergen, they bind to MC surface Fc-receptors 
and cause the MC to undergo characteristic biochemical 
and morphological changes and release their contents by 
degranulation.3,5 They release histamines, leukotriens, 
and prostaglandin in response to the antigen challenge.5 
Subsequent exposure leads to immediate degranulation 
and release of the chemical mediators.3 MC and their 
proteases increase in inflammatory conditions and bring 
about alterations in the basement membrane that allows 
cytotoxic lymphocytes to enter the epithelium.2
MC in periodontitis: The exact role of MC in inflammation 
is not yet known but their presence has been interpreted 
as a sign of healing. MC count is decreased in acute gin-
givitis but increased in chronic gingivitis, chronic gener-
alized periodontitis, and in proliferative fibrotic lesions 
like phenytoin enlargement.19 The increase in MC count 
suggests the possible participation of these cells in the 
defensive and the destructive events of chronic inflam-
mation. MC express matrix metalloproteinase (MMP) 
which are enzymes that degrade the gingival ECM, and 
they are known to release preformed cytokines which 
initiate immune response.20
MC in periapical lesion: MC are now recognized for its 
immunoregulatory properties, but little is known about 
the complex interactions between the cells, cytokines, and 
other inflammatory elements in periapical lesions. They 
tend to be more in the peripheral regions of periapical 
lesions and are found in close proximity to lymphocytes 
in both periapical granulomas and cysts.21 A functional 
relationship exists between these two cell populations and 
may facilitate elicitation of an immune response i.e., con-
tributory to the pathogenesis of the periapical lesions.21
MC in oral lichen planus (OLP): A specific pattern of MC 
distribution in mucous membrane diseases like OLP, 
pemphigoid, and desquamative gingivitis has been 
described by various researchers.10 They are increased 
significantly in OLP.10,22 They contain proinflammatory 
TNF-α in their granules, the release of which promotes 
leukocyte infiltration through the induction of endothe-
lial leukocyte adhesion molecules. TNF induces lesional 
T-cells to secrete chemokine RANTES, which stimulates 
MC degranulation.22 The expression of RANTES and its 
receptors on MC and T-cells prolong the survival of these 
cells and thus induce inflammation.22 The association 
of MC with laminin was an important determinant of 
MC density in the immediate perivascular region, thus 
providing an ideal situation for MC-derived mediators 
to influence the circular endothelium and cause the pro-
gression of OLP.22
MC in oral submucous fibrosis (OSMF): MC was observed 
in all the grades of OSMF. In grade I and II, they were 
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identified predominantly near the blood vessels where 
the reaction of the tissues to the irritants were strong.23 
MC were low in advanced stages where the connective 
tissue was hyalinized.23 The MC and vascular response 
in OSMF was similar to those identified in autoimmune 
diseases.24 Researchers claim that MC histamine chain 
causes changes in the submucosa and basement mem-
brane that lead to cancerous change in OSMF. The MC 
response in OSMF is consistent with the overall sequen-
tial tissue response in the disease. The smooth muscle 
hypertrophy in OSMF could be due to the degranulating 
MC products.24
MC in leukoplakia: Researchers found an increase in MC 
in epithelial dysplasia, suggesting a probable role in 
its pathogenesis.25 The biological and pharmacological 
active agents in MC may contribute to the inflamma-
tory reaction seen in leukoplakia. The stimulated MC 
release IL-1 causes increased keratinocyte proliferation.26 
Histamine increases mucosal permeability that facilitate 
increased access for the antigen to the connective tissue. 
MC mediators IL-1, TNF, histamine, and heparin could 
lead to the various histopathological and clinical features 
identified in leukoplakia.25 MC response was significantly 
greater in precancerous epithelial dysplasia than in overt 
carcinoma.27
MC in Oral Squamous Cell Carcinoma (OSCC): MC are said 
to play a defensive role in tumor growth. Studies suggest 
that MC exert an inhibitory effect on tumor growth and 
that the inhibitory factor could be serotonin.27 Tissue MC 
are usually absent or extremely sparse in deeper regions 
of carcinoma but tend to accumulate in the adjoining 
normal tissue and in the regional lymph nodes.2 The 
density of MC consistently decreased with increasing 
dedifferentiation and with increasing numbers of mitotic 
figures. In high MC group the overall survival rate was 
double that for the group with few MC.28 In tumor 
models MC have shown to play a decisive role in induc-
ing the angiogenic switch which precedes malignant 
transformation.17 The number of MC and microvascu-
lature were found to be higher in OSCC, suggesting that 
MC may upregulate tumor angiogenesis by expressing 
tryptase. MCTC were significantly increased at tumor 
invasion zone where both ECM degradation and angio-
genesis are required. MCT were found at the intratumoral 
stroma where angiogenesis was required.7,29
CONCLUSION
MC serve as the gate keepers of microvasculature due 
to their unique distribution and properties in health and 
disease. They exhibit an array of adhesion molecules, 
immune response receptors, and other surface mol-
ecules that give them the capability to react to multiple 
nonspecific and specific stimuli. There is no disease, bio-
logical condition, or animal model till date that exhibits 
an absolute lack of MC from which or in which their 
exact biological role could be studied in detail. MC and 
its mediators have a definite role to play in the patho-
genesis of many pathological conditions. They have been 
regarded as being important in the initiation and amplifi-
cation of acute inflammatory responses. In tumor models, 
MC have been shown to play a decisive role in inducing 
angiogenesis which precedes malignant transformation. 
We hope that this review recognizes the integral role of 
MC in oral pathological disorders and help researchers in 
the development of novel interventions to help improve 
the quality of life in these patients.
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